Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Genes|April 3, 2021
DNA Methylation at ATP11A cg11702988 Is a Biomarker of Lung Disease Severity in Cystic Fibrosis: A Longitudinal StudyFanny Pineau, Davide Caimmi, Sylvie Taviaux, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
Glucocorticoid receptors signaling impairment potentiates amyloid-β oligomers-induced pathology in an acute model of Alzheimer's diseaseGeoffrey Canet, Fanny Pineau, Charleine Zussy, et al.
Epigenomics|July 28, 2018
Dynamic changes of DNA methylation and lung disease in cystic fibrosis: lessons from a monogenic diseaseMilena Magalhães, Jörg Tost, Fanny Pineau, et al.
Neuroimage. Clinical|May 29, 2023
Brain dysfunction in gait disorders of Caribbean atypical Parkinsonism and progressive supranuclear palsy patients: A comparative studyMarie-Laure Welter, Alexandre Vasseur, Regine Edragas, et al.
JMIR Formative Research|April 3, 2024
Prospective Acceptability of Digital Therapy for Major Depressive Disorder in France: Multicentric Real-Life StudyOdile Amiot, Anne Sauvaget, Isabelle Alamome, et al.
Parkinsonism & Related Disorders|March 14, 2019
French validation of the questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale (QUIP-RS)Ana Marques, Tiphaine Vidal, Bruno Pereira, et al.
Parkinsonism & Related Disorders|September 1, 2020
Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutationsGraziella Mangone, Samir Bekadar, Florence Cormier-Dequaire, et al.
Neurology|March 21, 2014
Optimal target localization for subthalamic stimulation in patients with Parkinson diseaseMarie-Laure Welter, Michael Schüpbach, Virginie Czernecki, et al.
The Lancet. Neurology|February 18, 2018
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trialEugénie Lhommée, Lars Wojtecki, Virginie Czernecki, et al.
Neurology|February 10, 2019
Quality of life predicts outcome of deep brain stimulation in early Parkinson diseaseW M Michael Schuepbach, Lisa Tonder, Alfons Schnitzler, et al.
Pageof 2